| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |